Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-ketoglutarate dehydrogenase complex (α-KGDH or KGDHC) is a large mitochondrial enzyme complex that catalyzes the oxidative decarboxylation of alpha-ketoglutarate to succinyl-CoA and CO₂ in the citric acid (Krebs) cycle. This reaction also produces NADH, which directly supplies electrons to the respiratory chain for ATP production. Impaired function of this enzyme has been found to be characteristic for several neurodegenerative diseases.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-Ketoglutarate Dehydrogenase Complex (α-KGDH).